BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Genetown

  Kinaset Therapeutics to Present KN-002 Phase 1 Clinical Study Outcomes at the 2024 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting

  Kinaset Therapeutics today announced an upcoming oral presentation at the 2024 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting being held on February 23-26, 2024.

  December 7, 2023

   · 

  1 min read
• Lexaria’s Investigational New Drug Application Filing Update

  Lexaria Bioscience Corp. announces that the Company’s anticipated submission of an Investigational New Drug application with the U.S. Food and Drug Administration for its planned U.S. Phase 1b Hypertension Clinical Trial is expected to be filed within approximately 45 days.

  December 7, 2023

   · 

  6 min read
• Biotech Beach

  Camino Pharma receives $1.97M Small Business Innovation Research (SBIR) Grant from the National Institute of Alcohol Abuse and Alcoholism

  Camino Pharma, LLC announced that its co-founder and CSO, Reto Gadient, Ph.D., has been awarded a two-year, $1.97M grant by the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health under Award Number U43AA031388 and is the Principal Investigator on the grant.

  December 7, 2023

   · 

  4 min read
• BioMidwest

  GIE Medical Announces First Patient Enrolled in PATENT-E Benign Esophageal Stricture Treatment Study

  GIE Medical, a clinical stage company developing solutions for patients suffering from benign stricture(s) of the esophagus or bowel, announced today that enrollment has begun in its Paclitaxel Coated Balloon for the Treatment of Chronic Benign Stricture - Esophagus (PATENT-E) study.

  December 7, 2023

   · 

  2 min read
• Artificial Intelligence Could Speed Drug Discovery Market in Upcoming Years

  The global AI in drug discovery market size will hit around USD 15.44 billion by 2032 and growing at a CAGR of 29.66% from 2023 to 2032.

  December 7, 2023

   · 

  8 min read
• Telehealth Market Poised to Surge USD 1,186.59 Billion by 2032

  The global telehealth market in terms of revenue was estimated to be worth USD 120.01 billion in 2022 and is poised to reach USD 1,186.59 billion by 2032, growing at a CAGR of 25.7% from 2023 to 2032.

  December 7, 2023

   · 

  8 min read
• Lone Star Bio

  FibroBiologics to Host Investor Day

  FibroBiologics, Inc. today announced that it will hold an Investor Day on December 14, 2023.

  December 7, 2023

   · 

  2 min read
• Biotech Beach

  ACTG Announces Launch of Clinical Trial Evaluating Novel Treatment for Tuberculous Meningitis

  ACTG today announced the opening of the IMAGINE-TBM study (Improved Management with Antimicrobial AGents Isoniazid rifampiciN LinEzolid for TBM, also known as A5384).

  December 7, 2023

   · 

  4 min read
• Biosimilar Market Size to Surpass Around USD 1,26,019.67 Million by 2032

  The global biosimilar market size was estimated at USD 25,125.36 million in 2022 and is projected to surpass around USD 1,26,019.67 million by 2032, growing at a CAGR of 17.6% between 2023 and 2032.

  December 7, 2023

   · 

  8 min read
• Justera Announces 2023 AGM Results

  Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) (“Justera” or the “Company”) announces the voting results from the Annual General and Special Meeting of Shareholders (the “Meeting”) which was held on December 6, 2023.

  December 7, 2023

   · 

  3 min read